Legal Representation
Attorney
Glenn Gundersen
USPTO Deadlines
Next Deadline
128 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
December 10, 2025
Extension Available
Until December 10, 2025
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 6, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 6, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 6, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 10, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 29, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 29, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 9, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 21, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 20, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 20, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 20, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 4, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 4, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 4, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 12, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 9, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 16, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing news and information about medical research to patients and their caregivers in the fields of cancers, rare diseases, primary immune disorders and other diseases and related treatments and pharmaceuticals
Class 044
Providing health and medical news and information to patients and their caregivers in the fields of cancers, rare diseases, primary immune disorders and other diseases and related treatments and pharmaceuticals; providing patients and their caregivers with automated medical treatment reminders; providing news and information about access to treatments and pharmaceuticals to patients and their caregivers in the fields of cancers, rare diseases, primary immune disorders and other diseases
Class 045
providing personal support services for patients with cancers, rare diseases, primary immune disorders and other diseases and their caregivers, namely, helping with medical forms
Additional Information
Pseudo Mark
X FOR CONNECT
Pseudo Mark
X FOUR CONNECT
Classification
International Classes
042
044
045